Merck KGaA
MKKGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,318,000 | $5,255,000 | $5,280,000 | $5,418,000 |
| % Growth | 1.2% | -0.5% | -2.5% | – |
| Cost of Goods Sold | $2,105,000 | $2,228,000 | $2,135,000 | $2,319,000 |
| Gross Profit | $3,213,000 | $3,027,000 | $3,145,000 | $3,099,000 |
| % Margin | 60.4% | 57.6% | 59.6% | 57.2% |
| R&D Expenses | $660,000 | $539,000 | $551,000 | $527,000 |
| G&A Expenses | $332,000 | $354,000 | $355,000 | $415,000 |
| SG&A Expenses | $1,460,000 | $1,476,000 | $1,467,000 | $1,049,000 |
| Sales & Mktg Exp. | $1,128,000 | $1,122,000 | $1,112,000 | $634,000 |
| Other Operating Expenses | -$128,000 | $121,000 | $121,000 | $699,000 |
| Operating Expenses | $1,992,000 | $2,136,000 | $2,139,000 | $2,275,000 |
| Operating Income | $1,221,000 | $891,000 | $1,006,000 | $824,000 |
| % Margin | 23% | 17% | 19.1% | 15.2% |
| Other Income/Exp. Net | -$99,000 | -$62,000 | -$50,000 | -$16,000 |
| Pre-Tax Income | $1,122,000 | $829,000 | $956,000 | $808,000 |
| Tax Expense | $225,000 | $174,000 | $218,000 | $140,000 |
| Net Income | $902,000 | $652,000 | $735,000 | $667,000 |
| % Margin | 17% | 12.4% | 13.9% | 12.3% |
| EPS | 0.41 | 0.3 | 0.34 | 0.31 |
| % Growth | 36.7% | -11.8% | 9.7% | – |
| EPS Diluted | 0.41 | 0.3 | 0.34 | 0.31 |
| Weighted Avg Shares Out | 2,178,744 | 2,173,889 | 2,174,556 | 2,174,731 |
| Weighted Avg Shares Out Dil | 2,178,744 | 2,173,889 | 2,174,556 | 2,174,731 |
| Supplemental Information | – | – | – | – |
| Interest Income | $27,000 | $17,000 | $28,000 | $22,000 |
| Interest Expense | $126,000 | $79,000 | $78,000 | $59,000 |
| Depreciation & Amortization | $458,000 | $457,000 | $473,000 | $551,000 |
| EBITDA | $1,706,000 | $1,365,000 | $1,507,000 | $1,419,000 |
| % Margin | 32.1% | 26% | 28.5% | 26.2% |